Darifenacin HBr
| CAS No. | 133099-07-7 | Cat. No. | BCP05215 |
| Name | Darifenacin HBr | ||
| Synonyms | Darifenacin hydrobromide; | ||
| Formula | C28H30N2O2.HBr | M. Wt | 507.47 |
| Description | Darifenacin exerts non-parallel rightward displacement of the agonist curve and also significant depression of the maximum response (+)-cis-Dioxolane produced concentration-dependent contraction of the isolated bladder of rat. Darifenacin produces a concentration dependent increase in R123 (P-gp probe) accumulation in MDCK cells. Darifenacin stimulates ATPase activity in P-gp membrane in a clear concentration dependent response manner with an estimated ED50 value of 1.6?μM. Darifenacin (100 nM) shows a significantly greater permeability for darifenacin in the basolateral to apical direction resulting in an efflux ratio in BBMEC monolayers of approximately 2.6. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | mAChR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.